Market Place
Sourcing Support
All News #Library
Biotech
Pluristyx Expands Universal Cell Therapy Patent Portfolio
07 Apr 2026 //
GLOBENEWSWIRE
Pluristyx Launches Organoid Commons Revolutionizing Drug
02 Dec 2025 //
GLOBENEWSWIRE
Pluristyx, Breakthrough T1D Develop Immune-Cloaked T1D Cells
17 Nov 2025 //
GLOBENEWSWIRE
Pluristyx Executes Key Clinical Use Licenses for iPSC Portfolio
05 Nov 2025 //
GLOBENEWSWIRE
Pluristyx, BioLamina Partner on Stem Cell Therapy Work
04 Sep 2025 //
GLOBENEWSWIRE
Pluristyx Raises Funds to Boost Product Portfolio and Operations
28 Jul 2025 //
BUSINESSWIRE
Teknova & Pluristyx Launch PluriFreeze Cryopreservation System
19 Mar 2025 //
GLOBENEWSWIRE
Teknova, Pluristyx Partner To Streamline Cell Therapy Manufacturing
11 Mar 2025 //
GLOBENEWSWIRE
Pluristyx Receives U.S. Patent for iACT Stealth™ Technology
11 Feb 2025 //
BUSINESSWIRE
Humacyte & Pluristyx to Support BioVascular Pancreas Using iPSCs
28 Jan 2025 //
GLOBENEWSWIRE
Pluristyx Launches GMP-Compliant PSXi013 iPSC Line
07 Jan 2025 //
BUSINESSWIRE
Pluristyx Launches PluriFreeze Cryopreservation Media
04 Apr 2024 //
CONTRACT PHARMA
BioCentriq And Pluristyx Strengthen Partnership For IPSC-NK Cell Therapies
07 Mar 2024 //
PRESS RELEASE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.